Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
0.05% cyclosporine ophthalmic emulsion in moderate to severe dry eye
CTR20140800Phase 3Active
- Sponsor
- Sichuan Industrial Institute of Antibiotics
- Start
- Dec 2014
- Modality
- Small Molecules, Peptides
- Countries
- 1
01
Overview
A Phase 3 trial of cyclosporine in dry eye syndrome (DED), sponsored by Sichuan Industrial Institute of Antibiotics. Started Dec 2014; status: active.
02
Drugs
cyclosporine
03
Conditions
dry eye syndrome (DED)
Beyond the preview
Go deeper on CTR20140800.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20140800.